Invasive pneumococcal disease
Pneumococcal diseases are symptomatic infections caused by the bacterium Streptococcus pneumoniae (S. pneumoniae), commonly referred to as pneumococci. The term invasive pneumococcal disease (IPD) is used for more severe and invasive pneumococcal infections, such as bacteraemia, sepsis, meningitis and osteomyelitis, in which the bacterium can be isolated from normally sterile sites. Pneumococcal infections and IPDs are major causes of communicable disease morbidity and mortality in Europe and globally, with the highest burden of disease found in young children and the elderly. A large proportion of IPD is vaccine preventable.
Despite good access to effective antibiotics, Streptococcus pneumoniae (pneumococci) is still a major cause of disease and death in both developing and developed countries.
Policy briefings, guidance, expert opinions, risk assessments and peer-reviewed publications
ECDC promotes the performance of external quality assessment (EQA) schemes, in which laboratories are sent simulated clinical specimens or bacterial isolates for testing by routine or reference laboratory methods.
External quality assessment (EQA) of performance of laboratories participating in the European Antimicrobial Resistance Surveillance Network (EARS-Net), 2019
Automated digital reporting of clinical laboratory information to national public health surveillance systems, results of a EU/EEA survey, 2018